Maintenance chemotherapy in advanced ovarian cancer

A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus.

Gynecologic oncology·2024

Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218.

Gynecologic oncology·2019

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective.

Current oncology (Toronto, Ont.)·2011

The MIT D-lab electricity-free PortaTherm™ incubator for remote testing with the QuantiFERON®-TB Gold In-Tube assay.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2010